Genetic Technologies Ltd has released a press release.
Supplementary Announcement - Comprehensive Risk Test
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Genetic Technologies Announces US$5M Registered Direct Offer
- World First Comprehensive Risk Test-Breast & Ovarian Cancer
- GTG to form Strategic Alliance with global leader QIAGEN
- Appendix 4C and Quarterly Business Update December 2022
- Colorectal Cancer Model Presented at ASCOGI Cancer Symposium
Later from Genetic Technologies
- Business Update - February 2023
- Publication Highlights geneType Outperforms Current Models
- Receipt of R&D Tax Incentive Refund for geneType Multi Test
- Appendix 4D & Half-year Financial Report December 2022
- Further Study Validates geneType Breast Cancer Risk Test
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies